Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents.
- DOI
- 10.1038/s41380-025-03377-3
- Published
- 2026 Apr
- Container
- Molecular psychiatry
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41380-025-03377-3,
title = {Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents.},
author = {Soler-Cedeño O and Zhang HY and Xiong E and Bi GH and Alton H and Maras M and Liu QR and Bhattacharjee P and Iyer MR and Xi ZX},
year = {2026},
journal = {Molecular psychiatry},
doi = {10.1038/s41380-025-03377-3},
url = {https://doi.org/10.1038/s41380-025-03377-3}
}RIS
TY - JOUR TI - Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents. AU - Soler-Cedeño O AU - Zhang HY AU - Xiong E AU - Bi GH AU - Alton H AU - Maras M AU - Liu QR AU - Bhattacharjee P AU - Iyer MR AU - Xi ZX PY - 2026 JO - Molecular psychiatry DO - 10.1038/s41380-025-03377-3 UR - https://doi.org/10.1038/s41380-025-03377-3 ER -
APA
O, S., HY, Z., E, X., GH, B., H, A., M, M., QR, L., P, B., MR, I., & ZX, X. (2026). Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents.. Molecular psychiatry. https://doi.org/10.1038/s41380-025-03377-3
Source records
- pubmed · retrieved 2026-09-26T21:47:18.597Z